These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9986709)

  • 1. The presence of substituents on the aryl moiety of the aryl phosphoramidate derivative of d4T enhances anti-HIV efficacy in cell culture: A structure-activity relationship.
    Siddiqui AQ; Ballatore C; McGuigan C; De Clercq E; Balzarini J
    J Med Chem; 1999 Feb; 42(3):393-9. PubMed ID: 9986709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite.
    McGuigan C; Cahard D; Sheeka HM; De Clercq E; Balzarini J
    J Med Chem; 1996 Apr; 39(8):1748-53. PubMed ID: 8648614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anti-HIV activity of some novel chain-extended phosphoramidate derivatives of d4T (stavudine): esterase hydrolysis as a rapid predictive test for antiviral potency.
    McGuigan C; Tsang HW; Sutton PW; De Clercq E; Balzarini J
    Antivir Chem Chemother; 1998 Mar; 9(2):109-15. PubMed ID: 9875382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus.
    Uckun FM; Pendergrass S; Qazi S; Samuel P; Venkatachalam TK
    Eur J Med Chem; 2004 Mar; 39(3):225-34. PubMed ID: 15051170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diastereoselective synthesis of aryloxy phosphoramidate prodrugs of 3'-deoxy-2',3'-didehydrothymidine monophosphate.
    Roman CA; Balzarini J; Meier C
    J Med Chem; 2010 Nov; 53(21):7675-81. PubMed ID: 20945915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, anti-human immunodeficiency virus activity and esterase lability of some novel carboxylic ester-modified phosphoramidate derivatives of stavudine (d4T).
    McGuigan C; Sutton PW; Cahard D; Turner K; O'Leary G; Wang Y; Gumbleton M; De Clercq E; Balzarini J
    Antivir Chem Chemother; 1998 Nov; 9(6):473-9. PubMed ID: 9865385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D4T-5'-[p-bromophenyl methoxyalaninyl phosphate] as a potent and non-toxic anti-human immunodeficiency virus agent.
    Vig R; Venkatachalam TK; Uckun FM
    Antivir Chem Chemother; 1998 Sep; 9(5):445-8. PubMed ID: 9875398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bis-cycloSal-d4T-monophosphates: drugs that deliver two molecules of bioactive nucleotides.
    Ducho C; Görbig U; Jessel S; Gisch N; Balzarini J; Meier C
    J Med Chem; 2007 Mar; 50(6):1335-46. PubMed ID: 17328534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and anti-HIV activity of phosphoramidate derivatives of D4T-MP with variations in the amino acid moiety.
    Naesens L; Cahard D; Salgado A; Bidois L; De Clercq E; McGuigan C; Balzarini J
    Adv Exp Med Biol; 1998; 431():753-7. PubMed ID: 9598164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine.
    Saboulard D; Naesens L; Cahard D; Salgado A; Pathirana R; Velazquez S; McGuigan C; De Clercq E; Balzarini J
    Mol Pharmacol; 1999 Oct; 56(4):693-704. PubMed ID: 10496951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of lipophilic phosphoramidate d4T-MP prodrugs expressing high potency against HIV in cell culture: structural determinants for in vitro activity and QSAR.
    Siddiqui AQ; McGuigan C; Ballatore C; Zuccotto F; Gilbert IH; De Clercq E; Balzarini J
    J Med Chem; 1999 Oct; 42(20):4122-8. PubMed ID: 10514282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the hydrolysis pathways of substituted aryl phosphoramidate versus aryl thiophosphoramidate derivatives of stavudine.
    Venkatachalam TK; Yu G; Samuel P; Qazi S; Pendergrass S; Uckun FM
    Eur J Med Chem; 2004 Aug; 39(8):665-83. PubMed ID: 15276300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncharged AZT and D4T derivatives of phosphonoformic and phosphonoacetic acids as anti-HIV pronucleosides.
    Shirokova EA; Jasko MV; Khandazhinskaya AL; Ivanov AV; Yanvarev DV; Skoblov YS; Mitkevich VA; Bocharov EV; Pronyaeva TR; Fedyuk NV; Kukhanova MK; Pokrovsky AG
    J Med Chem; 2004 Jul; 47(14):3606-14. PubMed ID: 15214788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoramidate and phosphate prodrugs of (-)-beta-D-(2R,4R)-dioxolane-thymine: synthesis, anti-HIV activity and stability studies.
    Liang Y; Narayanasamy J; Schinazi RF; Chu CK
    Bioorg Med Chem; 2006 Apr; 14(7):2178-89. PubMed ID: 16314108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cycloSal-2',3'-dideoxy-2',3'-didehydrothymidine monophosphate (cycloSal-d4TMP): synthesis and antiviral evaluation of a new d4TMP delivery system.
    Meier C; Lorey M; De Clercq E; Balzarini J
    J Med Chem; 1998 Apr; 41(9):1417-27. PubMed ID: 9554875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of change in nucleoside structure on the activation and antiviral activity of phosphoramidate derivatives.
    Venkatachalam TK; Samuel P; Qazi S; Uckun FM
    Bioorg Med Chem; 2005 Sep; 13(18):5408-23. PubMed ID: 15994083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyfluoroaromatic stavudine (d4T) ProTides exhibit enhanced anti-HIV activity.
    Kandil S; Pannecouque C; Chapman FM; Westwell AD; McGuigan C
    Bioorg Med Chem Lett; 2019 Dec; 29(24):126721. PubMed ID: 31679972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro enzymatic and antiviral evaluation of phosphoramidate d4T derivatives as chain terminators.
    Yang S; Pannecouque C; Lescrinier E; Giraut A; Herdewijn P
    Org Biomol Chem; 2012 Jan; 10(1):146-53. PubMed ID: 22069085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: chitosan-O-isopropyl-5'-O-d4T monophosphate conjugate.
    Yang L; Chen L; Zeng R; Li C; Qiao R; Hu L; Li Z
    Bioorg Med Chem; 2010 Jan; 18(1):117-23. PubMed ID: 19959368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives.
    McGuigan C; Hassan-Abdallah A; Srinivasan S; Wang Y; Siddiqui A; Daluge SM; Gudmundsson KS; Zhou H; McLean EW; Peckham JP; Burnette TC; Marr H; Hazen R; Condreay LD; Johnson L; Balzarini J
    J Med Chem; 2006 Nov; 49(24):7215-26. PubMed ID: 17125274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.